baber/WOPTO huggingface dataset:
Patent AT-E282119-T1 (AT)
Inventor: ADDERTON DAVID JOHN
IPC: E04B2/74
Filed: 1999-01-14
Granted: 2004-11-15
Abstract: A panel support assembly 25 comprises a post 10 having at least one elongate recess 12, rotatably supporting a respective panel receiving member 13. The panel receiving member 13 comprising a rod-like member having an internal channel 14 adapted to receive a panel 11. The recess 12 is part-cylindrical and respective panel receiving member 14 is cylindrical, partially fitting within recess 12, so as to allow relative rotation. A pair of panel support assemblies 25, with pairs of panel receiving members 13 facing each other, provides a panel fixing system for fixing a panel 11.
Patent AT-E319083-T1 (AT)
Inventor: BOWERS WILLIAM D
IPC: G01N29/22
Filed: 1999-09-03
Granted: 2006-03-15
Abstract: A device for detecting chemical substances includes a plurality of sensors arranged in an array. The sensors are connected to respective oscillator circuits which drive the sensors, and the oscillator circuits are coupled to a power multiplexer which provides the circuits with power according to a timing pattern such that not all of the oscillator circuits are activated at any one time. Preferably, only one oscillator circuit is activated at any given time. This multiplexing arrangement saves power and substantially eliminates cross talk between the oscillator circuits. The oscillator circuits are preferably application specific integrated circuits (ASICs), and the sensors are preferably surface acoustic wave (SAW) devices. In use, the SAW sensors are exposed to a gas, such as air, containing the chemical substance to be detected. Signals from the SAW sensors are analyzed to identify the chemical substance.
Patent AT-E236545-T1 (AT)
Inventor: VINDRIIS SOEREN
IPC: A43B13/12
Filed: 1999-10-15
Granted: 2003-04-15
Abstract: The invention relates to an insole for footwear. The insole comprises a top foil and a bottom foil in between which a number of cavities are formed containing liquid or gel. The top foil and/or bottom foil are equipped with fabric which in the plane of the fabric has a tensile strength that is higher than the tensile strength of the top and/or the bottom foil. Thereby, the fabric prevents creep of the plastic of which the top foil and/or the bottom foil usually are made. Preferentially, the fabric is joined with the foil such that the fabric extends on the outside or at least to the outside the foil. Thereby, the fabric constitutes a layer between the sole and the bottom of the footwear and, respectively, between the sole and the foot or the sock/stocking on the foot. Thereby, it is possible to select the frictional conditions such that the sole lies firmly in the footwear and such that the foot slides easily on the sole in order to reduce the formation of heat to the foot as a result of friction.
Patent AT-E307649-T1 (AT)
Inventor: BRITSCH LOTHAR
IPC: G01N30/46
Filed: 1999-12-04
Granted: 2005-11-15
Abstract: Continuous separation methods, in partricular using SMB methods, are disclosed, in which the analytes are separated by size exclusion chromatography (gel permeation chromatography).
Patent AT-E276316-T1 (AT)
Inventor: GUENTHERBERG NORBERT
IPC: C08F265/04
Filed: 1999-12-16
Granted: 2004-10-15
Abstract: Thermoplastic molding compositions comprising(A) 5 to 98%-wt., based on components (A) through (E), of at least one elastomeric graft copolymer,(B) 1 to 90%-wt., based on components (A) through (E), of a further copolymer,(C) 1 to 70%-wt., based on components (A) though (D), of an elastomeric block copolymer composed ofat least one block CA (hard phase) having copolymerized units of a vinylaromatic monomer, andat least one elastomeric block C(B/A) (soft phase) having copolymerized units of a vinylaromatic monomer, and of a diene,(D) 0 to 300%-wt., based on components (A) through (C), of a polycarbonate, and(E) 0 to 30%-wt., based on components (A) through (E), of conventional additives and processing aids,are useful for producing films, moldings or fibers.
Patent AT-E315336-T1 (AT)
Inventor: HACKER ERWIN
IPC: A01N33/18
Filed: 1999-09-20
Granted: 2006-02-15
Abstract: The invention relates to synergistic herbicidal combinations for controlling harmful plants in plant cultures. The combinations contain active substances (A) et (B). (A) is an amino triazine with a partial structure of formula (I) as claim 1, in short T-NR-L-M, and L and M are defined as in claim 1, T is a 1,3,5-triazine and NR is an optionally substituted amino group, and (B) is one or more herbicides from the group of compounds consisting of (B1) leaf and/or soil-acting herbicides that are effective against monocotyledonous harmful plants. (B2) herbicides that are chiefly effective against dicotyledonous harmful plants and (B3) herbicides that are effective against monocotyledonous or dicotyledonous harmful plants are optionally (B4) herbicides that are effective against monocotyledonous and dicotyledonous harmful plants which can especially be used in tolerant cultures or on non-cultivated soil, with the exception of combinations of herbicides if the formula (I'), wherein R<1>=H or methyl; X=Cl, F and A=a phenoxy methyl group which is unsubstituted at the phenyl ring or which is substituted with one or two radicals from the methyl and fluorine group, or a benzofuran-2-yl or benzothiophen-2-yl radical, with herbicides selected from the group of isoproturon, diclofop methyl, fenoxapropethyl and amidosulfuron.
Patent DE-20702333-T1 (DE)
Title: Etikettenfreies Detektionsverfahren zur Charakterisierung des Verhaltens einer Komponente in einer Flüssigkeit
Inventor: LEEMAN MATS
IPC: G01N30/00
Filed: 2020-02-05
Abstract: Markierungsfreies Verfahren zur Charakterisierung einer ersten Komponente in einer komplexen Flüssigprobe, wobei das Verfahren umfasst:(a) Bereitstellen einer komplexen Flüssigprobe, die die erste Komponente umfasst;(b) Durchführen einer Feld-Fluss-Fraktionierung (FFF) an der Probe;(c) Erhalten einer Vielzahl von Fraktionen der Probe aus (b);(d) Durchführen eines markierungsfreien Detektionsverfahrens, das für die erste Komponente selektiv ist, an den Fraktionen;(e) Erhalten eines Ausgangssignals von dem markierungsfreien Detektionsverfahren;(f) Analysieren des Ausgangssignals, um das Vorliegen der ersten Komponente innerhalb der Fraktionen zu bestimmen, wodurch die erste Komponente als in monomerer Form und/oder in aggregierter Form vorliegend charakterisiert wird,wobei die monomere Form die erste Komponente oder ein Fragment der ersten Komponente umfasst oder aus dieser besteht, undwobei die aggregierte Form zwei oder mehrere Kopien der ersten Komponente oder die erste Komponente zusammen mit einer oder mehreren weiteren Komponenten der komplexen Flüssigprobe umfasst oder daraus besteht.
Patent DE-193502-T1 (DE)
IPC: F16H61/14
Filed: 1986-02-24
Abstract: A servo friction-clutch device for automating the clutch operation in motor vehicles of any kind, said device comprising a cylinder that includes one or two seal chambers, (10, 11) a membrane (12) running within said cylinder, said membrane (12) being connected through a shaft (13) and some mechanical means (14, 15, 26, 26') to the clutch pedal or to the equivalent leverage; a three-way solenoid valve (1) whose commutation is actuated through the accelerator pedal or gas pedal, or through the acceleration circuit of the vehicle; a small vent piston (21) which is in communication with said cylinder and is connected direct or indirect to the clutch pedal or to said equivalent leverage and is operatively actuated by the vehicle carburetor; and a one-way vent solenoid valve (30) that is actuated by a frequency generator connected to the tachometer.
Patent DE-285471-T1 (DE)
IPC: C12N5/00
Filed: 1988-03-02
Abstract: The method for obtaining a skin equivalent (27) involves preparing a dermis equivalent (24) by mixing contractile cells, a nutrient medium and collagen so as to form a gel which contracts; using this dermis equivalent (24) as a substrate for an epidermis equivalent (26) obtained by sowing with the keratinocytes from an animal or human explant. According to the invention, the substrate (24) is sown with at least one section of a hair follicle (22) comprising at least partially its cellular sheath, the said section being implanted substantially perpendicular to the free surface of the substrate. <IMAGE>
Patent DE-353450-T1 (DE)
IPC: C07K16/30
Filed: 1989-06-23
Abstract: A group of functionalized polyaminocarboxylate chelants that form complexes with rare earth-type metal ions are disclosed. The complexes can be covalently attached to an antibody or antibody fragment and used for therapeutic and/or diagnostic purposes.
Patent CY-1107124-T1 (CY)
Inventor: SPEISER MATTHIAS
IPC: H01R25/00
Filed: 2008-01-03
Abstract: An installation device (10) has a bottom part (12) and upper part (11). The bottom part exhibits an opening (15) which is lockable with a flap lid (16). The cable inlet openings (17) are guided in the hollow space and the screwless cable connection clamps (23) are mounted in the hollow space.
Patent CY-1110531-T1 (CY)
Inventor: ALLEN JOHN GORDON
IPC: C07D417/12
Filed: 2009-10-02
Abstract: The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2C receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: R6 D R?N—R″R* where R6 is —(CrC3)alkyl-S—(C0-C3)alkyl-R10, —(C1-C3)alkyl-NR11R12, —(CrC3)alkyl-O—R13. and other substituents are as defined in the specification.
Patent CY-1109892-T1 (CY)
Title: Φυτα ανθεκτικα στην πιεση
Inventor: DE BLOCK MARC
IPC: C12N15/82
Filed: 2010-03-12
Abstract: Η ανθεκτικότητα στην πίεση από τα φυτά και τα φυτικά κύτταρα επιτυγχάνεται με τη χρήση των αλληλουχιών νουκλεοτιδίων κωδικοποίησης ενζύμων στη μέθοδο σύνθεσης απόπλυσης NAD ή/και τη μέθοδο σύνθεσης NAD de novo π.χ. για υπερ-έκφραση στα φυτά.
Patent CY-1113611-T1 (CY)
Title: Ενδοφθαλμικος φακος
Inventor: AMON MICHAEL
IPC: A61F2/16
Filed: 2012-09-10
Abstract: Ένας ενδοφθαλμικός φακός περιλαμβάνει μία οπτική διάταξη και δύο ή περισσότερες απτικές διατάξεις, όπου η οπτική διάταξη είναι κυρτή/κοίλη, δηλαδή και οι δύο επιφάνειες είναι καμπύλες κατά την ιδία φορά σε σχέση προς το επίπεδο, το οποίο ορίζεται από την περιθωριακή ζώνη της οπτικής διάταξης, όπου οι οπτικές διατάξεις ευρίσκονται υπό μία γωνία σε σχέση προς το εν λόγω επίπεδο και επί της ιδίας πλευράς αυτού, όπως οι επιφάνειες των οπτικών διατάξεων και όπου εκάστη απτική διάταξη έχει μία ομαλή ακτινικά κυματοειδή εξωτερική ακμή.
Patent CY-1118931-T1 (CY)
Title: 2'-μεθυλ-νουκλεοζιδια σε συνδυασμο με ιντερφερονη και μεταλλαξη των flaviviridae
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: C12Q1/70
Filed: 2017-04-19
Abstract: Η παρούσα εφεύρεση αποκαλύπτει μια μέθοδο για την αγωγή της λοίμωξης από Flaviviridae που συμπεριλαμβάνει τη χορήγηση ενός 2'-διακλαδισμένου νουκλεοζιδίου, ή ενός φαρμακευτικώς αποδεκτού προφαρμάκου και/ή άλατος εξ' αυτού, σε έναν άνθρωπο σε ανάγκη θεραπείας σε συνδυασμό ή εναλλαγή με ένα φάρμακο που επάγει αμέσως ή εμμέσως μια μετάλλαξη στο ιικό γονιδίωμα σε μια θέση άλλη από μια μετάλλαξη ενός νουκλεοτιδίου που έχει ως αποτέλεσμα μια αλλαγή από σερίνη σε ένα διαφορετικό αμινοξύ στην κατεξοχήν συντηρημένη συναινετική αλληλουχία, την XRXSGXXXT, της επικράτειας Β της περιοχής πολυμεράσης RNA, ή που συσχετίζεται με μια τέτοια μετάλλαξη. Η εφεύρεση συμπεριλαμβάνει επίσης μια μέθοδο για ανίχνευση ενός στελέχους μεταλλάγματος των Flaviviridae και μια μέθοδο για την αγωγή αυτού.
Patent CY-1124491-T1 (CY)
Title: Σωματιδια πολυμερους και χρησεις αυτων
Inventor: REHM BERND HELMUT ADAM
IPC: C07K19/00
Filed: 2021-09-09
Abstract: Η παρούσα αίτηση αναφέρεται σε σωματίδια πολυμερούς και χρήσεις αυτών. Αυτά τα σωματίδια πολυμερούς περιλαμβάνουν πρωτεΐνες σύντηξης, όπου οι πρωτεΐνες σύντηξης περιλαμβάνουν μια πρωτεΐνη σχηματισμού σωματιδίων και τουλάχιστον και τουλάχιστον 2 αντιγόνα που επιλέγονται απότα ESTA6, CFP10, Rv3615 και Rv3020. Αυτά τα πολυμερή χρησιμοποιούνται για να σχηματίσουν συνθέσεις και διαγνωστικά αντιδραστήρια. Αυτά τα πολυμερή, οι συνθέσεις και τα διαγνωστικά αντιδραστήρια πρόκειται να χρησιμοποιηθούν σε μεθόδους ανίχνευσης Μ. tuberculosis και Μ. bovis, και σε μεθόδους διάγνωσης Μ. tuberculosis και Μ. Bovis.
Patent HR-P20090219-T1 (HR)
Title: Bullet-proof separating wall construction
Inventor: KROMER GEORG
IPC: E04H9/10
Filed: 2009-04-10
Abstract: A shot proof wall system has single or multi layer outer panels (11, 12) over double inner panels (23, 24) of fibre reinforced plaster. The inner and outer panels are secured onto metal profile supports using threaded fasteners. The plaster and fibre panels can have a layered construction, e.g. plaster and fibre and metal. The structure provides a progressive absorption of projectiles including shot and shrapnel.
Patent HR-P20110431-T1 (HR)
Title: Inactivated poliovirus combination vaccine
Inventor: HERVE DE HEMPTINNE
IPC: A61K39/295
Filed: 2011-06-09
Abstract: The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.
Patent HR-P20110553-T1 (HR)
Inventor: CHEN XIN
IPC: C07D487/04
Filed: 2011-07-25
Abstract: Spoj prikazan sa formulom (I)  (I) ili njegova farmaceutski prihvatljiva sol, naznačen time da: X1, C (E1)aa;X2 je N ili C (E1)aa;X3 i X5 su N; X4, X6, i X7 su C; R3 je vodik, C1-10alkil, cikloC3-10alkil, aminometilcikloC3-10alkil, bicikloC5-10alkil, aril, heteroaril, aralkil, heteroaralkil, heterociklil ili heterobicikloC5-10alkil bilo koji od njih je proizvoljno supstituiran sa jednim ili više nezavisnih G11 supstituenata;  Q1 je -A(R1)mB(W)n ili -B(G11)nA(Y)m;A i B su odgovarajući, 5 i 6 člani aromatski ili heteroaromatski prstenovi, kondenzirani zajedno da formiraju 9-člani heteroaromatski sustav odabran od indolila, benzimidazolila, benzoksazolila, benzofuranila i benzotienila, ali isključujući 5-benzo[b]furil i 3-indolil; R1 je nezavisno, vodik, -N(C0-8alkil)(C0-8alkil), hidroksil, halogen, okso, aril (proizvoljno supstituiran sa 1 ili više R31 skupina), hetaril (proizvoljno supstituiran sa 1 ili više R31 skupina), C1-6alkil, -C0-8alkilC3-8cikloalkil, -C0-8alkil NR311S(O)0-2R321, -C0-8alkil NR311S(O)0-2NR321R331, -C0-8alkil S(O)0-2NR311R321, -C0-8alkil NR311COR321, -C0-8alkil NR311CO2R321, -C0-8alkil NR311CONR321R331, -C0-8alkil CONR311R321, -C0-8alkil CON(R311)S(O)0-2R321, -C0-8alkil-CO2R311,  C0-8alkil-S(O)0-2R311, -C0-8alkil O C1-8alkil, -C0-8alkil-O-C0-8alkilC3-8cikloalkil, -C0-8alkil-O-C0-8alkilheterociklil, -C0-8alkil-O-C0-8alkilaril, -C0-8alkilaril, -C0-8alkilhetaril, -C0-8alkilheterociklil, -C0-8alkil-O-C0-8alkilhetaril, -C0-8alkil S C0-8alkil, -C0-8alkil-S-C0-8alkilC3-8cikloalkil, -C0-8alkil-S-C0-8alkilheterociklil,  C0-8alkil-S-C0-8alkilaril, -C0-8alkil-S-C0-8alkilhetaril, -C0-8alkil N(R311) C0-8alkil, -C0-8alkil-N(R311)-C0-8alkilC3-8cikloalkil, -C0-8alkil-N(R311)-C0-8alkilheterociklil, -C0-8alkil-N(R311)-C0-8alkilaril, -C0-8alkil-N(R311)-C0-8alkilhetaril, -C0-8alkil-NR311R321-C2-8alkenil,  C2-8alkinil, NO2, CN, CF3, OCF3, OCHF2; pod uvjetom da Q1 nije N-metil-2-indolil, ili N-(fenilsulfonil)-2-indolil; W je nezavisno, vodik, -N(C0-8alkil)(C0-8alkil), hidroksil, halogen, okso, aril (proizvoljno supstituiran sa 1 ili više R31 skupina), hetaril (proizvoljno supstituiran sa 1 ili više R31 skupina), C1-6alkil, -C0-8alkilC3-8cikloalkil, -C0-8alkil NR312S(O)0-2R322, -C0-8alkil NR311S(O)0-2NR321R331, -C0-8alkil NR311CO2R321, -C0-8alkil CON(R311)S(O)0-2R321, -C0-8alkil S(O)0-2NR312R322, -C0-8alkil NR312COR322, -C0-8alkil NR312CONR322R332, -C0-8alkil CONR312R322, -C0-8alkil-CO2R312, -C0-8alkilS(O)0-2R312, -C0-8alkil O C1-8alkil, 4-C0-8alkil-O-C0-8alkilciklil, -C0-8alkil-O-C0-8alkilheterocikloalkil, -C0-8alkil-O-C0-8alkilaril, -C0-8alkilaril, -C0-8alkilhetaril, -C0-8alkilheterociklil, -Oaril, -C0-8alkil-O-C0-8alkilhetaril, -C0-8alkil S C0-8alkil, -C0-8alkil-S-C0-8alkilC3-8cikloalkil, -C0-8alkil-S-C0-8alkilheterocikloalkil, -C0-8alkil-S-C0-8alkilaril, -C0-8alkil-S-C0-8alkilhetaril, -C0-8alkil N(R312) C0-8alkil, -C0-8alkil-N(R312)-C0-8alkilC3-8cikloalkil, -C0-8alkil-N(R312)-C0-8alkilheterocikloalkil, -C0-8alkil-N(R312)-C0-8alkilaril, -C0-8alk
Patent HR-P20130962-T1 (HR)
Title: Decreasing potential iatrogenic risks associated with vaccine antigens
Inventor: GREGERSEN JENS PETER
IPC: C12N5/0784
Filed: 2013-10-10
Abstract: The inventor has realised that certain pathogens can grow in mammalian cells, in particular Vero cells, and that these pathogens could pose a contamination risk when producing vaccine antigens in these cells. The invention thus provides methods to test for these pathogens.
Patent SI-1453798-T1 (SI)
Title: (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Inventor: DELUCA HECTOR F
IPC: A61K31/00
Filed: 2002-12-12
Abstract: This invention discloses (20S)-1 alpha -hydroxy-2-methylene-19-nor-bishomopregnacalciferol, pharmaceutical uses therefor, and a method of purifying this compound to obtain it in crystalline form. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Patent SI-1737438-T1 (SI)
Title: Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome
Inventor: BESANA CLAUDIA
IPC: A61K45/00
Filed: 2005-04-19
Abstract: Certain ±-aminoamide derivatives for use in the treatment of addictive disorders are disclosed. The compounds of this invention are able to reduce or even stop the symptoms of addictive disorders substantially without side effects.
Patent SI-1670110-T1 (SI)
Title: End plate for cable conduits
Inventor: EBERLE PATRICK
IPC: H02G3/00
Filed: 2005-11-26
Abstract: An end-plate has five separate elements (10-50). One plate is the base plate (10) with a terminal board (170 matched to the wiring and cabling arrangement channel, and two pairs of pins (32,52) matched terminal-wise to the opening (15) in the base plate (10). An extension (41') of the intermediate plate (40) carries a pin (44) terminal-wise matched to the opening (15) and an opening (45) terminal-wise matched to the opening pin (22) of the other intermediate plate (20). An extension (51') of the corner plate (50) carries a pair of pins (54) terminal-wise matched to the openings (15) of the base plate (10).
Patent SI-2281831-T1 (SI)
Title: Varicella Zoster virus vaccine
Inventor: HANON EMMANUEL JULES
IPC: C07K14/00
Filed: 2006-03-01
Abstract: Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL arc also claimed.
Patent SI-2101792-T1 (SI)
Title: Use of carrageenan for treating rhinovirus infections
Inventor: GRASSAUER ANDREAS
IPC: A61K31/00
Filed: 2007-12-04
Abstract: The present invention provides for the use of iota-, kappa- or lambdacarrageenan or mixtures thereof for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a rhinovirus infection.
Patent SI-2875011-T1 (SI)
Title: 5-ht3 receptor antagonists
Inventor: HITCHCOCK STEPHEN
IPC: C07D519/00
Filed: 2013-07-16
Abstract: The present invention provides compounds of the formula: that are 5HT3 receptor antagonists and are therefore useful for the treatment of diseases treatable by inhibition of 5HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Patent TR-200102112-T1 (TR)
Inventor: PETEREIT HANS-URICH
IPC: A61K9/20
Filed: 2000-11-29
Abstract: The invention relates to a process for making molded articles by means of injection molding with the process steps of a) melting of a (meth)acrylate copolymer, which is composed of 30 to 80 wt % of radical-polymerized C1 to C4 alkyl esters of acrylic or methacrylic acid and 70 to 20 wt % of (meth)acrylate monomers with a tertiary ammonium group in the alkyl residue, wherein the (meth)acrylate copolymer is present in a mixture with 1 to 70 wt % of a plasticizer and a desiccant in the ratio of 1:1 to 1:20 and also with 0.05 to 5 wt % of a release agent, and further standard additives or adjuvants and if necessary even a pharmaceutical active principle can also be present in the mixture, and before the mixture is melted it has a content of more than 0.5 wt % of low-boiling constituents with a vapor pressure of at least 1.9 bar at 120° C., b) degassing of the mixture in the thermoplastic condition at temperatures of at least 120° C., whereby the content of low-boiling constituents with a vapor pressure of at least 1.9 bar at 120° C. is lowered to at most 0.5 wt % and c) injection of the melted and degassed mixture into the mold cavity of an injection-molding die, wherein the mold cavity has a temperature which lies at least 10° C. below the glass transition temperature of the (meth)acrylate copolymer, cooling of the melt mixture and removal of the obtained molded article from the mold.
Patent DE-3382704-T2 (DE)
Inventor: CABEZON THERESA
IPC: C12N15/81
Filed: 1983-09-06
Granted: 1994-02-10
Abstract: A DNA fragment capable of coding for HBsAg and DNA derivatives of Dane particles is fused to the region for controlling the arg3 gene of yeast and cloned in a yeast vector. The recombinant vector is employed for transforming the competent yeast cells in which the HBsAg gene is expressed.
Patent DE-3486318-T2 (DE)
Inventor: SCHMITZ THOMAS R
IPC: F16L21/00
Filed: 1984-12-06
Granted: 1994-09-22
Abstract: An apparatus for joining two tubular members B and P together at a subsea location wherein one of the tubular members has internal grooves 90, 92, 94 and the second tubular member is sufficiently small to slide into the first tubular member and the first tubular member has an external flange suitable for connection to a flowline, which apparatus includes a tubular mandrel 10 having means for connecting to said first tubular member B, a resilient sleeve 60a surrounding said mandrel and adapted to be positioned within said second tubular member P, volume compensating means 98 positioned within each of said grooves and testing means 70 carried by said mandrel to allow testing of the joint while the mandrel is still in position after forming. A method of joining tubular members at a subsea location including the steps of inserting the second tubular member within the first tubular member after the volume compensators have been inserted in the internal grooves in the first member, exerting fluid pressure on the interior of the second tubular to form the second tubular member against the internal grooves of the first tubular member and testing the formed joint while the mandrel is still in position within said second tubular member.A second form of the invention includes the use of microspheres in an epoxy matrix positioned in internal grooves of the bell which are designed to collapse at pressures above the water pressure at the depth of the installation of the joint and at a pressure below the pressures which develop in trapped sea water in the groove during forming.